Abstract
Background. Little research is available comparing differences in cancer risk perceptions between cancer survivors and family members at risk for hereditary breast/ovarian cancer.Methods. Qualitative focus groups with survivor-female relative dyads (N=39) were conducted.Results. Important differences exist between the concerns of survivors and family members relevant to their cancer risk. Survivors focused on their own concerns from a personal perspective, whereas family members focused on the survivors’ health and tended to suppress their own fears of cancer. Specific recommendations for inclusion of family members in cancer risk education are provided.Conclusions. Addressing family member differences is critical to tailor specific risk information inclusive of the entire family.
Similar content being viewed by others
References
McInerney-Leo A, Biesecker BB, Hadley DW, et al. BRCA1/2 testing in hereditary breast and ovarian cancer families II: Impact on relationships. Am J Med Genet A. 2005;133:165–169.
Centers for Disease Control and Prevention, Office of Genomics and Disease Prevention. Genomics and Population Health: United States 2003. Atlanta, GA: Centers for Disease Control and Prevention; 2004.
DeVries H, Mesters I, van de Steeg H, Honing C. The general public’s information needs and perception regarding hereditary cancer: an application of the integrated change model. Pub Educ Couns. 2005;56:154–165.
Bodzin J, Kardia SLR, Goldenberg A, et al. Genomics and public health: development of Web-based training tools for increasing genomic awareness. Prev Chronic Dis [serial online]. April 4, 2005. Available at: http:// www.cdc.gov/pcd/issues/2005/apr/04_0133.htm. Accessed 15 June, 2005.
Miki Y, Swensen J, Shattuck-Eidens, et al. A strong candidate for the breast and ovarian cancer susceptibility gene BRCA1. Science. 1994;266:66–71.
Tavtigian SV, Simnard J, Rommens J, et al. The complete BRCA2 gene and mutations in chromosome 13q-linked kindreds. Nat Genet. 1996;12:333–337.
Wooster R, Bignell G, Lancaster J, et al. Identification of the breast cancer susceptibility gene BRCA2. Nature. 1995;378:789–792.
Ford D, Easton DF, Stratton M, et al. Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families. The breast cancer linkage consortium. Am J Hum Genet. 1998;62:676–689.
Satagopan JM, Offit K, Foulkes W, et al. The lifetime risk of breast cancer in Ashkenazi Jewish carriers of BRCA1 and BRCA2 mutations. Cancer Epidemiol Biomarkers Prev. 2001;10:467–473.
Struewing JP, Lerman C, Kase RG, et al. The risk of cancer associated with specific mutations of BRCA1 and BRCA2 among Ashkenazi Jews. N Engl J Med. 1997; 336:1401–1408.
Kreuter MW. Dealing with competing and conflicting risks in cancer communication. J Natl Cancer Inst Monogr. 1999;25:27–35.
Lanie AD, Jayaratne TE, Sheldon JP, et al. Exploring the public understanding of basic genetic concepts. J Genet Couns. 2004;13:305–320.
Croyle RT, Lerman C. Risk communication in genetic testing for cancer susceptibility. J Natl Cancer Inst Monogr. 1999;25:59–66.
Lerman C, Croyle RT, Terczak KP, et al. Genetic testing: psychological aspects and implications. J Consult Clin Psychol. 2002;70:784–797.
Kenen R, Ardern-Jones A, Eeles R. We are talking, but are they listening? communication patterns in families with a history of breast/ovarian cancer (HBOC) Psychooncology. 2003;13:335–345.
d’Agincourt-Canning L. The effect of experiential knowledge on construction of risk perception in hereditary breast/ovarian cancer. J Genet Couns. 2005;2004:55–69.
Lobb EA, Butow P, Barratt A, et al. Differences in individual approaches: communication in the familial breast cancer consultation and the effect on patient outcomes. J Genet Couns. 2005;14:43–53.
Wang C, Gonzalez R, Merajver SD. Assessment of genetic testing and related counseling services: current research and future directions. Soc Sci Med. 2004;58:1427–1442.
Appleton S, Watson M, Rush R, et al. A randomized controlled trial of a psycho-educational intervention for women at increased risk of breast cancer. Br J Cancer. 2004;90:41–47.
Weinstein ND. Why it won’t happen to me: perceptions of risk factors susceptibility. Health Psychol. 1984;3:431–457.
Weinstein ND. Unrealistic optimism about susceptibility to health problems: conclusions from a community-wide sample. J Behav Med. 1987;10:481–500.
Biesecker BB, Ishibe N, Hadley DW. Psychosocial factors predicting BRCA1/BRCA2 testing decisions in members of hereditary breast and ovarian cancer families. Am J Med Genet. 2000;93:257–263.
Green J, Richards M, Murton F, et al. Family communication and genetic counseling: the case of hereditary breast and ovarian cancer. J Genet Couns. 1997;6:45–60.
Forrest K, Simpson SA, Wilson BJ, et al. To tell or not to tell: barriers and facilitators in family communication about genetic risk. Clin Genet. 2003;64:317–326.
Coyne JC, Anderson KK. Marital status, marital satisfaction, and support processes among women at high risk for breast cancer. J Fam Psychol. 1999;13:629–641.
Hughes C, Lerman C, Schwartz M, et al. All in the family: evaluation of the process and consent of sisters’ communication about BRCA1 and BRCA2 genetic test results. Am J Med Genet. 2002;107:143–150.
Manne S, Markowitz A, Winawer S, et al. Correlates of colorectal cancer screening compliance and stage of adoption among siblings of individuals with early onset colorectal cancer. Health Psychol. 2002;21:3–15.
Claes E, Evers-Kiebooms G, Boogaerts A, et al. Communication with close and distant relatives in the context of genetic testing for hereditary breast and ovarian cancer in cancer patients. Am J Med Genet A. 2003;116:11–19.
Koehly SM, Peterson SK, Watts BG, et al. A social network analysis of communication about hereditary colorectal cancer genetic testing and family functioning. Cancer Epidemiol Biomarkers Prev. 2003; 12:304–313.
Hamilton RJ, Bowers BJ, Williams JK. Disclosing genetic test results to family members. Image J Nurs Scholarsh. 2005;37:18–24.
Jacobsen PB, Valdimarsdottier HB, Brown KL, et al. Decision-making about genetic testing among women at familial risk for breast cancer. Psychosom Med. 1997;59:459–466.
Lerman C, Seay J, Balshem A, et al. Interest in genetic testing among first-degree relatives of breast cancer patients. Am J Med Genet. 1995;57:385–392.
Mellon S, Berry-Bobovski L, Gold R, et al. Communication and decision-making about seeking inherited cancer risk information: findings from female survivor-relative focus groups. Psychooncology. 2006;15:193–208.
QSR International Pty Ltd. QSR NVivo: New Generation Software for Qualitative Analysis [computer program] Version. Doncaster, Victoria, Australia: QSR International Pty Ltd; 2002.
Mellon S. Comparisons between cancer survivors and family members on meaning of the illness and family quality of life. Oncol Nurs Forum. 2002;29:1–9.
Taylor EJ. Transformation of tragedy among women surviving breast cancer. Oncol Nurs Forum. 2000;27:781–788.
Hilton BA, Crawford JA, Tarko MA. Men’s perspectives on individual and family coping with their wives’ breast cancer and chemotherapy. West J Nurs Res. 2000;22:438–459.
Zahlis EH, Shands ME. Breast cancer: demands of the illness on the patient’s partner. J Psychosoc Oncol. 1991;9:75–93.
Rimer BK, Schildkraut JM, Lerman C, et al. Participation in a women’s breast cancer risk counseling trial: who participates? Who declines? Cancer. 1996;77:2348–2355.
Author information
Authors and Affiliations
Corresponding author
Additional information
Supported by The Barbara and Fred Erb Endowed Chair in Cancer Genetics to M.A. Tainsky and research funds from the Karmanos Cancer Institute. The findings from this research resulted in an award from the National Institute of Nursing Research, National Institutes of Health, R21 NR008584-01.
Rights and permissions
About this article
Cite this article
Mellon, S., Berry-Bobovski, L., Gold, R. et al. Concerns and recommendations regarding inherited cancer risk: The perspectives of survivors and female relatives. J Canc Educ 22, 168–173 (2007). https://doi.org/10.1007/BF03174331
Issue Date:
DOI: https://doi.org/10.1007/BF03174331